Analysts are extremely encouraged by Phase 2 trial results for Relay Therapeutics’ PI3KA inhibitor in treating vascular ...
The new 3-Phase Sequence/Loss/Undervoltage Monitoring Relay series is a state-of-the-art relay designed to address critical power quality issues such as incorrect ...
3don MSN
Relay Therapeutics reports early success for investigational drug in rare vascular disorders
Relay Therapeutics Inc. RLAY reported initial Phase 2 data for zovegalisib in patients with vascular anomalies, with the ...
Showing a significant efficacy signal in a phase II trial, Relay Therapeutics Inc.’s zovegalisib (RLY-2608) achieved a 60% ...
AutomationDirect has added new phase and voltage monitoring relays from ProSense. The PMRU-2C series true RMS phase monitor relays protect 3-phase equipment from damage that can occur when there is a ...
Zovegalisib + atirmociclib + AI selected as triplet regimen for frontline developmentCompelling efficacy and tolerability data for zovegalisib ...
The PMRU-2C series true RMS phase monitor relays protect 3-phase equipment from damage that can occur when there is a phase loss, phase reversal, phase unbalance, undervoltage or overvoltage condition ...
HAWTHORNE, Calif.--(BUSINESS WIRE)--Teledyne Relays, a leading provider of cutting-edge relay solutions, introduces its new 3-Phase Monitoring Relay. The new 3-Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results